SPX3,779.45-5.93 -0.16%
DIA307.17-0.65 -0.21%
IXIC10,996.39-32.35 -0.29%

--Maxim Group Initiates Coverage on Virpax Pharmaceuticals With Buy Rating, $4 Price Target

MT Newswires · 06/09/2022 06:31

Please log in to view news